Figure 8.

Distribution of AUIC in patients with gametocytes in Thailand in different treatment groups. Only patients with gametocytes are presented: 253 patients out of 2864 (9%) in the Artemisinin +Other group, 16 out of 298 (5%) in the Halofantrine group and 113 out of 775 (15%) patients in the Mefloquine group. Patients who had any missing gametocytes measurements on day 0, 7, 14, 28 were not included unless the missing values occurred after the day of gametocyte clearance.